Combining Ruxolitinib With Donor Regulatory T Cells May Outperform Monotherapy in Chronic Graft Vs Host Disease
Pretreatment Peripheral Blood Inflammatory Indices May Have Prognostic Value in Myelodysplastic Syndrome